Vandross, A.
28  Ergebnisse:
Personensuche X
?
1

Phase 1 Study of the Tissue Factor–Targeting Antibody-Drug ..:

Ulahannan, S. ; Johnson, M. ; Weiss, M....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e31-e32 , 2024
 
?
2

133P Phase I/II study of XTX101: A masked, tumor-activated ..:

Davar, D. ; Knecht, J.G. ; Vandross, A.L....
Immuno-Oncology and Technology.  20 (2023)  - p. 100605 , 2023
 
?
4

A Phase 1 study of the anti-tissue factor antibody-drug con..:

Ulahannan, S. ; Johnson, M.L. ; Park, H....
European Journal of Cancer.  174 (2022)  - p. S92-S93 , 2022
 
?
9

Case Reports in the Age of Twitter:

Cifu, Adam S. ; Vandross, Andrae L. ; Prasad, Vinay
The American Journal of Medicine.  132 (2019)  10 - p. e725-e726 , 2019
 
?
10

Copanlisib Has Activity As a Single Agent and in Combinatio..:

Larson, Sarah ; Peng, Mao Yu ; Vandross, Andrae...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e132 , 2017
 
?
12

Failing to improve overall survival because post-protocol s..:

Prasad, Vinay ; Vandross, Andrae
Journal of Cancer Research and Clinical Oncology.  140 (2014)  4 - p. 521-524 , 2014
 
?
14

Publication Trends Among Internal Medicine Residents and Gr..:

Prasad, Vinay ; Rho, Jason ; Selvaraj, Senthil...
The American Journal of Medicine.  125 (2012)  9 - p. 939-944 , 2012
 
?
15

Name-Calling:

Vandross, Andrae
Journal of General Internal Medicine.  28 (2012)  1 - p. 162-163 , 2012
 
1-15